236 related articles for article (PubMed ID: 22236408)
21. Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas.
Garandeau D; Noujarède J; Leclerc J; Imbert C; Garcia V; Bats ML; Rambow F; Gilhodes J; Filleron T; Meyer N; Brayer S; Arcucci S; Tartare-Deckert S; Ségui B; Marine JC; Levade T; Bertolotto C; Andrieu-Abadie N
Mol Cancer Ther; 2019 Feb; 18(2):289-300. PubMed ID: 30482853
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate.
Kharel Y; Mathews TP; Gellett AM; Tomsig JL; Kennedy PC; Moyer ML; Macdonald TL; Lynch KR
Biochem J; 2011 Dec; 440(3):345-53. PubMed ID: 21848514
[TBL] [Abstract][Full Text] [Related]
23. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.
Yan G; Chen S; You B; Sun J
Cardiovasc Res; 2008 May; 78(2):308-14. PubMed ID: 18192241
[TBL] [Abstract][Full Text] [Related]
24. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
Maiti A; Takabe K; Hait NC
Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
[TBL] [Abstract][Full Text] [Related]
25. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
26. Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathways.
Feng Y; Barile E; De SK; Stebbins JL; Cortez A; Aza-Blanc P; Villanueva J; Heryln M; Krajewski S; Pellecchia M; Ronai ZA; Chiang GG
Pigment Cell Melanoma Res; 2011 Aug; 24(4):703-13. PubMed ID: 21592316
[TBL] [Abstract][Full Text] [Related]
27. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.
Kohno M; Momoi M; Oo ML; Paik JH; Lee YM; Venkataraman K; Ai Y; Ristimaki AP; Fyrst H; Sano H; Rosenberg D; Saba JD; Proia RL; Hla T
Mol Cell Biol; 2006 Oct; 26(19):7211-23. PubMed ID: 16980623
[TBL] [Abstract][Full Text] [Related]
28. SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway.
Liu H; Zhang CX; Ma Y; He HW; Wang JP; Shao RG
Life Sci; 2016 Apr; 151():23-29. PubMed ID: 26944438
[TBL] [Abstract][Full Text] [Related]
29. Identification of WEE1 as a target to make AKT inhibition more effective in melanoma.
Kuzu OF; Gowda R; Sharma A; Noory MA; Kardos G; Madhunapantula SV; Drabick JJ; Robertson GP
Cancer Biol Ther; 2018 Jan; 19(1):53-62. PubMed ID: 28853983
[TBL] [Abstract][Full Text] [Related]
30. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.
Watson DG; Tonelli F; Alossaimi M; Williamson L; Chan E; Gorshkova I; Berdyshev E; Bittman R; Pyne NJ; Pyne S
Cell Signal; 2013 Apr; 25(4):1011-7. PubMed ID: 23314175
[TBL] [Abstract][Full Text] [Related]
31. Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.
Pchejetski D; Doumerc N; Golzio M; Naymark M; Teissié J; Kohama T; Waxman J; Malavaud B; Cuvillier O
Mol Cancer Ther; 2008 Jul; 7(7):1836-45. PubMed ID: 18644996
[TBL] [Abstract][Full Text] [Related]
32. SphK1 confers resistance to apoptosis in gastric cancer cells by downregulating Bim via stimulating Akt/FoxO3a signaling.
Xiong H; Wang J; Guan H; Wu J; Xu R; Wang M; Rong X; Huang K; Huang J; Liao Q; Fu Y; Yuan J
Oncol Rep; 2014 Oct; 32(4):1369-73. PubMed ID: 25109605
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion.
Lv M; Zhang D; Dai D; Zhang W; Zhang L
Inflamm Res; 2016 Jul; 65(7):551-62. PubMed ID: 27002656
[TBL] [Abstract][Full Text] [Related]
34. Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting sphingolipid rheostat.
Han J; Zhao P; Shao W; Wang Z; Wang F; Sheng L
Pharmacol Rep; 2018 Oct; 70(5):853-862. PubMed ID: 30092415
[TBL] [Abstract][Full Text] [Related]
35. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.
Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD
Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547
[TBL] [Abstract][Full Text] [Related]
36. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
Tanfin Z; Serrano-Sanchez M; Leiber D
Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
[TBL] [Abstract][Full Text] [Related]
37. The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism.
Tonelli F; Alossaimi M; Williamson L; Tate RJ; Watson DG; Chan E; Bittman R; Pyne NJ; Pyne S
Br J Pharmacol; 2013 Mar; 168(6):1497-505. PubMed ID: 23113536
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis.
Pchejetski D; Kunduzova O; Dayon A; Calise D; Seguelas MH; Leducq N; Seif I; Parini A; Cuvillier O
Circ Res; 2007 Jan; 100(1):41-9. PubMed ID: 17158340
[TBL] [Abstract][Full Text] [Related]
39. [Inhibitions of SphK1 inhibitor SKI II on cell cycle progression and cell invasion of hepatoma HepG2 cells].
Zhang CX; Liu H; Gong YY; He HW; Shao RG
Yao Xue Xue Bao; 2014 Feb; 49(2):204-8. PubMed ID: 24761610
[TBL] [Abstract][Full Text] [Related]
40. Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization.
Hengst JA; Hegde S; Paulson RF; Yun JK
Bioorg Med Chem Lett; 2020 Oct; 30(20):127453. PubMed ID: 32736077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
